| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DET0024707 | 1963-09-13 | ||
| DET0024706 | 1963-09-13 | ||
| FR987753AFR1444679A (en) | 1963-09-13 | 1964-09-10 | Process for manufacturing novel 5, 6-dihydro-morphanthridine derivatives |
| Publication Number | Publication Date |
|---|---|
| FR4016Mtrue FR4016M (en) | 1966-03-21 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR998054AExpiredFR4016M (en) | 1963-09-13 | 1964-12-09 |
| Country | Link |
|---|---|
| BE (1) | BE652938A (en) |
| CH (1) | CH430722A (en) |
| DE (1) | DE1470350B1 (en) |
| DK (2) | DK107553C (en) |
| FR (1) | FR4016M (en) |
| GB (1) | GB1068744A (en) |
| SE (1) | SE323683B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0409406A3 (en)* | 1989-06-19 | 1991-04-03 | The Wellcome Foundation Limited | Aryl-substituted amine derivatives useful in cancer therapy |
| US5208238A (en)* | 1989-06-19 | 1993-05-04 | Burroughs Wellcome Company | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5300282A (en)* | 1989-06-19 | 1994-04-05 | Burroughs-Wellcome Company | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5346897A (en)* | 1989-06-19 | 1994-09-13 | Burroughs Wellcome Co. | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5364843A (en)* | 1989-06-19 | 1994-11-15 | Burroughs Wellcome Co. | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2918832A1 (en)* | 1979-05-10 | 1980-11-20 | Basf Ag | 5,6-DIHYDRO-11-ALKYLENE-MORPHANETRIDINE-6-ONE |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0409406A3 (en)* | 1989-06-19 | 1991-04-03 | The Wellcome Foundation Limited | Aryl-substituted amine derivatives useful in cancer therapy |
| EP0487502A3 (en)* | 1989-06-19 | 1992-06-24 | The Wellcome Foundation Limited | Pharmaceutically active aryl-substituted amine derivatives |
| US5208238A (en)* | 1989-06-19 | 1993-05-04 | Burroughs Wellcome Company | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5300282A (en)* | 1989-06-19 | 1994-04-05 | Burroughs-Wellcome Company | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5346897A (en)* | 1989-06-19 | 1994-09-13 | Burroughs Wellcome Co. | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5364843A (en)* | 1989-06-19 | 1994-11-15 | Burroughs Wellcome Co. | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| US5395610A (en)* | 1989-06-19 | 1995-03-07 | Burroughs-Wellcome Co. | Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| Publication number | Publication date |
|---|---|
| DE1470350B1 (en) | 1970-04-02 |
| DK107553C (en) | 1967-06-12 |
| CH430722A (en) | 1967-02-28 |
| DK107483C (en) | 1967-06-05 |
| GB1068744A (en) | 1967-05-10 |
| BE652938A (en) | 1965-03-10 |
| SE323683B (en) | 1970-05-11 |